Adaptimmune
Adaptimmune is a biotechnology company that researches and develops T-cell receptors for the treatment of cancer and infectious diseases.
Business Model:
Revenue: $17.5M
Employees: 201-500
Rankings
Industries / Tags:
Detailed Adaptimmune Information
Geographic Data
Address: 60 Jubilee Avenue
City: Oxfordshire
State: england
Zip: OX14 4RX
Country: GB
Financial Info
Stage:
post ipo equity
Raised Last:
$150M
Raised Total:$400M
Social
Metrics
2,675,315Website Global Rank
6,565Website Monthly Traffic
Twitter Followers
Description
Adaptimmune is a biotechnology company that researches and develops T-cell receptors for the treatment of cancer and infectious diseases.
Contact Phone:
Contact Email:
Adaptimmune went public on 5/6/2015 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
5/6/2015
IPO Valuation:
$1B
Ticker Symbol:
ADAP
Amount Raised:
$191M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
